KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Non Operating Income (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Non Operating Income for 17 consecutive years, with -$256.0 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 312.9% to -$256.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$304.0 million through Dec 2025, down 139.37% year-over-year, with the annual reading at -$238.0 million for FY2025, 39.18% down from the prior year.
  • Non Operating Income hit -$256.0 million in Q4 2025 for Quest Diagnostics, down from -$58.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $284.0 million in Q2 2021 to a low of -$256.0 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$11.8 million across 5 years, with a median of -$3.0 million in 2023.
  • Biggest five-year swings in Non Operating Income: soared 1114.29% in 2021 and later crashed 1033.33% in 2024.
  • Year by year, Non Operating Income stood at $3.0 million in 2021, then crashed by 966.67% to -$26.0 million in 2022, then skyrocketed by 138.46% to $10.0 million in 2023, then crashed by 720.0% to -$62.0 million in 2024, then plummeted by 312.9% to -$256.0 million in 2025.
  • Business Quant data shows Non Operating Income for DGX at -$256.0 million in Q4 2025, -$58.0 million in Q3 2025, and $13.0 million in Q2 2025.